Publicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (42)

2024

  1. Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study

    ERJ Open Research, Vol. 10, Núm. 1

2023

  1. Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review

    Journal of Clinical Medicine, Vol. 12, Núm. 10

  2. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  3. Factors associated with suboptimal response to monoclonal antibodies in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology

  4. Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors

    Journal of Internal Medicine, Vol. 294, Núm. 1, pp. 69-82

  5. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

2022

  1. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

    European Respiratory Journal

  2. Author Correction: Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study (Scientific Reports, (2022), 12, 1, (3369), 10.1038/s41598-022-07414-x)

    Scientific Reports

  3. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  4. EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1667-1684

  5. Influence of the environment on the characteristics of asthma

    Scientific Reports, Vol. 12, Núm. 1

  6. Inhaled Colistimethate Sodium in the Management of Patients with Bronchiectasis Infected by Pseudomonas aeruginosa: A Narrative Review of Current Evidence

    Infection and Drug Resistance, Vol. 15, pp. 7271-7292

  7. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study

    Scientific reports, Vol. 12, Núm. 1, pp. 3369

  8. SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis

    Reumatologia Clinica, Vol. 18, Núm. 8, pp. 443-452

  9. SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment

    Reumatologia Clinica, Vol. 18, Núm. 9, pp. 501-512

2021

  1. Asthma 2020 Nursing Consensus Document

    Open Respiratory Archives, Vol. 3, Núm. 1

  2. Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis

    Scientific Reports, Vol. 11, Núm. 1

  3. Forum COPD Working Group Consensus on the Diagnosis, Treatment and Follow-Up of COPD

    Archivos de Bronconeumologia, Vol. 57, Núm. 9, pp. 596-599

  4. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792